Page last updated: 2024-11-04

sb 220025 and Adjuvant Arthritis

sb 220025 has been researched along with Adjuvant Arthritis in 1 studies

SB 220025: inhibits p38 mitogen-activated protein kinase; structure in first source
SB220025 : Am member of the class of imidazoles carrying piperidin-4-yl, 4-fluophenyl and 2-aminopyrimidin-4-yl substituents at posiitons 1, 4 and 5 respectively.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Graneto, MJ1
Kurumbail, RG1
Vazquez, ML1
Shieh, HS1
Pawlitz, JL1
Williams, JM1
Stallings, WC1
Geng, L1
Naraian, AS1
Koszyk, FJ1
Stealey, MA1
Xu, XD1
Weier, RM1
Hanson, GJ1
Mourey, RJ1
Compton, RP1
Mnich, SJ1
Anderson, GD1
Monahan, JB1
Devraj, R1

Other Studies

1 other study available for sb 220025 and Adjuvant Arthritis

ArticleYear
Synthesis, crystal structure, and activity of pyrazole-based inhibitors of p38 kinase.
    Journal of medicinal chemistry, 2007, Nov-15, Volume: 50, Issue:23

    Topics: Animals; Antirheumatic Agents; Arthritis, Experimental; Collagen; Crystallography, X-Ray; Male; Mice

2007